A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?

In this report, we present a 29-year-old African American female who was brought to a local emergency department after being found unresponsive by her mother. The etiology of her stroke and severe hemolysis remained unknown, despite her mother reporting the patient’s history of co-inheritance of sic...

Full description

Bibliographic Details
Main Authors: Ava Runge, Danielle Brazel, Zahra Pakbaz
Format: Article
Language:English
Published: Taylor & Francis Group 2021-09-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Online Access:http://dx.doi.org/10.1080/20009666.2021.1954285
id doaj-65b5a5d6f57c419383d150dbcf9b5816
record_format Article
spelling doaj-65b5a5d6f57c419383d150dbcf9b58162021-10-04T13:57:01ZengTaylor & Francis GroupJournal of Community Hospital Internal Medicine Perspectives2000-96662021-09-0111571371810.1080/20009666.2021.19542851954285A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?Ava Runge0Danielle Brazel1Zahra Pakbaz2University of California Irvine Medical CenterUniversity of California Irvine Medical CenterUniversity of California Irvine Medical CenterIn this report, we present a 29-year-old African American female who was brought to a local emergency department after being found unresponsive by her mother. The etiology of her stroke and severe hemolysis remained unknown, despite her mother reporting the patient’s history of co-inheritance of sickle cell trait and beta-thalassemia trait, and extensive workup during her prolonged hospitalization. She was diagnosed with sickle cell disease (Sβ+ type) two years after discharge when she was referred to a sickle cell specialist for persistent anemia. Here, we also briefly review the challenges to diagnose rarer subtypes of sickle cell disease (SCD), in this case Sβ+ type, as well as the pathophysiology and current management of stroke in SCD.http://dx.doi.org/10.1080/20009666.2021.1954285sickle cell diseasesickle cell beta-plus thalassemiacompound heterozygousstroke
collection DOAJ
language English
format Article
sources DOAJ
author Ava Runge
Danielle Brazel
Zahra Pakbaz
spellingShingle Ava Runge
Danielle Brazel
Zahra Pakbaz
A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
Journal of Community Hospital Internal Medicine Perspectives
sickle cell disease
sickle cell beta-plus thalassemia
compound heterozygous
stroke
author_facet Ava Runge
Danielle Brazel
Zahra Pakbaz
author_sort Ava Runge
title A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
title_short A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
title_full A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
title_fullStr A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
title_full_unstemmed A case of Sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
title_sort case of sβ+ sickle cell disease diagnosed in adulthood following acute stroke: it’s 2021, are we there yet?
publisher Taylor & Francis Group
series Journal of Community Hospital Internal Medicine Perspectives
issn 2000-9666
publishDate 2021-09-01
description In this report, we present a 29-year-old African American female who was brought to a local emergency department after being found unresponsive by her mother. The etiology of her stroke and severe hemolysis remained unknown, despite her mother reporting the patient’s history of co-inheritance of sickle cell trait and beta-thalassemia trait, and extensive workup during her prolonged hospitalization. She was diagnosed with sickle cell disease (Sβ+ type) two years after discharge when she was referred to a sickle cell specialist for persistent anemia. Here, we also briefly review the challenges to diagnose rarer subtypes of sickle cell disease (SCD), in this case Sβ+ type, as well as the pathophysiology and current management of stroke in SCD.
topic sickle cell disease
sickle cell beta-plus thalassemia
compound heterozygous
stroke
url http://dx.doi.org/10.1080/20009666.2021.1954285
work_keys_str_mv AT avarunge acaseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet
AT daniellebrazel acaseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet
AT zahrapakbaz acaseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet
AT avarunge caseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet
AT daniellebrazel caseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet
AT zahrapakbaz caseofsbsicklecelldiseasediagnosedinadulthoodfollowingacutestrokeits2021arewethereyet
_version_ 1716843968128352256